News Daily News TAVI and Complex/High-Risk PCI Safer if Staged, Registry Confirms Caitlin E. Cox April 28, 2025
News Conference News HRS 2025 GLP-1 Drugs May Have Role in Secondary Prevention of AF Todd Neale April 28, 2025
News Daily News Funding for Women’s Health Initiative Imperiled, but Appears Secure for Now Yael L. Maxwell April 25, 2025
News Conference News CX Symposium 2025 Plant-Derived Compound Shows Early Promise for Small AAAs L.A. McKeown April 25, 2025
News Conference News HVS 2025 Solid Durability Seen With Surgical Resilia Tissue Aortic Valve Yael L. Maxwell April 21, 2025
News Daily News High-Sensitivity Troponin Tests Might Aid in Primary Prevention Yael L. Maxwell April 16, 2025
News Daily News COMPARE-TAVI 1: Myval Performs Well Against Sapien at 1 Year Todd Neale April 11, 2025
News Conference News EHRA 2025 SWISS-APERO at 3 Years: Hints of Differences Between Amulet, Watchman Emerge Todd Neale April 09, 2025
News Conference News EHRA 2025 Positive Results With Volt Pulsed-Field Ablation System Todd Neale April 07, 2025
News Conference News ACC 2025 PCI Rebounds at 5 Years to Mostly Match CABG: Final FAME 3 Data Caitlin E. Cox March 31, 2025
News Conference News ACC 2025 By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE Michael O'Riordan March 31, 2025
News Conference News EHRA 2025 Pulsed-Field Ablation Equals, and May Top, Cryoablation for Paroxysmal AF Todd Neale March 31, 2025
News Conference News ACC 2025 More ALIGN-AR Data Bolster Potential for a Dedicated AR Device Yael L. Maxwell March 30, 2025
News Conference News ACC 2025 Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection Michael O'Riordan March 30, 2025
News Conference News ACC 2025 SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes Michael O'Riordan March 29, 2025
News Daily News ACC 2025 STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients L.A. McKeown March 29, 2025
News Conference News ACC 2025 WARRIOR: No Clear Answers on How to Best Treat INOCA Yael L. Maxwell March 29, 2025
News Conference News ACC 2025 Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT Caitlin E. Cox March 29, 2025
News Daily News Risk of Another Event Remains High for Years After TIA, Minor Stroke Todd Neale March 26, 2025